Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Shigdar

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Molecules (Basel, Switzerland)|December 6, 2019
Anything You Can Do, I Can Do Better: Can Aptamers Replace Antibodies in Clinical Diagnostic Applications?Michelle Bauer, Mia Strom, David S Hammond, et al.
Biochimie|September 26, 2022
Cytotoxic effects of aptamer-doxorubicin conjugates in an ovarian cancer cell lineJustin L Henri, Maryam Nakhjavani, Scott McCoombe, et al.
Nucleic Acid Therapeutics|February 11, 2016
The Application of Aptamers for ImmunohistochemistryMichelle Bauer, Joanna Macdonald, Justin Henri, et al.
Pharmaceutics|January 21, 2022
Profiling Cancer Cells by Cell-SELEX: Use of Aptamers for Discovery of Actionable Biomarkers and Therapeutic Applications ThereofSarah Shigdar, Lisa Agnello, Monica Fedele, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 19, 2021
Aptamers: Cutting edge of cancer therapiesSarah Shigdar, Brett Schrand, Paloma H Giangrande, et al.
Nucleic Acid Therapeutics|August 9, 2016
Truncation and Mutation of a Transferrin Receptor Aptamer Enhances Binding AffinityJoanna Macdonald, Patrick Houghton, Dongxi Xiang, et al.
Journal of Visualized Experiments : Jove|October 3, 2022
A Flow Cytometry-based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer AptamerMaryam Nakhjavani, Breanna Giles, Mia Strom, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 14, 2022
Modelling of mass transport and distribution of aptamer in blood-brain barrier for tumour therapy and cancer treatmentMohsen Sarafraz, Maryam Nakhjavani, Sarah Shigdar, et al.
Biochimie|December 12, 2017
Aptamers as potential therapeutic agents for ovarian cancerJustin Liam Henri, Joanna Macdonald, Mia Strom, et al.
ACS Chemical Neuroscience|December 25, 2016
Development of a Bifunctional Aptamer Targeting the Transferrin Receptor and Epithelial Cell Adhesion Molecule (EpCAM) for the Treatment of Brain Cancer MetastasesJoanna Macdonald, Justin Henri, Lynda Goodman, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Molecules (Basel, Switzerland)|December 6, 2019
Anything You Can Do, I Can Do Better: Can Aptamers Replace Antibodies in Clinical Diagnostic Applications?Michelle Bauer, Mia Strom, David S Hammond, et al.
Biochimie|September 26, 2022
Cytotoxic effects of aptamer-doxorubicin conjugates in an ovarian cancer cell lineJustin L Henri, Maryam Nakhjavani, Scott McCoombe, et al.
Nucleic Acid Therapeutics|February 11, 2016
The Application of Aptamers for ImmunohistochemistryMichelle Bauer, Joanna Macdonald, Justin Henri, et al.
Pharmaceutics|January 21, 2022
Profiling Cancer Cells by Cell-SELEX: Use of Aptamers for Discovery of Actionable Biomarkers and Therapeutic Applications ThereofSarah Shigdar, Lisa Agnello, Monica Fedele, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 19, 2021
Aptamers: Cutting edge of cancer therapiesSarah Shigdar, Brett Schrand, Paloma H Giangrande, et al.
Nucleic Acid Therapeutics|August 9, 2016
Truncation and Mutation of a Transferrin Receptor Aptamer Enhances Binding AffinityJoanna Macdonald, Patrick Houghton, Dongxi Xiang, et al.
Journal of Visualized Experiments : Jove|October 3, 2022
A Flow Cytometry-based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer AptamerMaryam Nakhjavani, Breanna Giles, Mia Strom, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 14, 2022
Modelling of mass transport and distribution of aptamer in blood-brain barrier for tumour therapy and cancer treatmentMohsen Sarafraz, Maryam Nakhjavani, Sarah Shigdar, et al.
Biochimie|December 12, 2017
Aptamers as potential therapeutic agents for ovarian cancerJustin Liam Henri, Joanna Macdonald, Mia Strom, et al.
ACS Chemical Neuroscience|December 25, 2016
Development of a Bifunctional Aptamer Targeting the Transferrin Receptor and Epithelial Cell Adhesion Molecule (EpCAM) for the Treatment of Brain Cancer MetastasesJoanna Macdonald, Justin Henri, Lynda Goodman, et al.
Pageof 6